Insulet
PODD
#1034
Rank
C$25.21 B
Marketcap
$359.09
Share price
5.23%
Change (1 day)
57.17%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): C$0.47 Billion

According to Insulet's latest financial reports the company's current earnings are C$2.07 Billion. , an increase over its 2023 earnings that were of C$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 C$0.47 B36.72%
2023 C$0.34 B481.9%
2022 C$59.66 M-45.24%
2021 C$0.10 B43.35%
2020 C$76 M18.51%
2019 C$64.13 M41.16%
2018 C$45.43 M-711.95%
2017 -C$7.43 Million-56.85%
2016 -C$17.21 Million-79.31%
2015 -C$83.19 Million63.85%
2014 -C$50.77 Million31.04%
2013 -C$38.75 Million-21.96%
2012 -C$49.65 Million
2010 -C$47.35 Million-42.38%
2009 -C$82.18 Million-33.56%
2008 -C$0.13 Billion65.93%
2007 -C$74.55 Million209.75%
2006 -C$24.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$56.1 M-88.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.13 Billion-127.25%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.00 B 112.31%๐Ÿ‡บ๐Ÿ‡ธ USA
C$24.14 B 4,986.61%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.70 B 1,945.20%๐Ÿ‡บ๐Ÿ‡ธ USA
C$8.27 B 1,643.66%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
C$17.55 B 3,597.99%๐Ÿ‡บ๐Ÿ‡ธ USA